Saudi Arabia Neuralgia Treatment Market Size & Outlook
Saudi Arabia neuralgia treatment market, 2016-2027 (US$M)
Related Markets
Saudi Arabia neuralgia treatment market highlights
- The Saudi Arabia neuralgia treatment market generated a revenue of USD 32.9 million in 2020 and is expected to reach USD 51.9 million by 2027.
- The Saudi Arabia market is expected to grow at a CAGR of 6.7% from 2021 to 2027.
- In terms of segment, surgery was the largest revenue generating treatment in 2020.
- Drug Based is the most lucrative treatment segment registering the fastest growth during the forecast period.
Neuralgia treatment market data book summary
| Market revenue in 2020 | USD 32.9 million |
| Market revenue in 2027 | USD 51.9 million |
| Growth rate | 6.7% (CAGR from 2020 to 2027) |
| Largest segment | Surgery |
| Fastest growing segment | Drug Based |
| Historical data | 2016 - 2019 |
| Base year | 2020 |
| Forecast period | 2021 - 2027 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Drug Based, Surgery |
| Key market players worldwide | GlaxoSmithKline Consumer Healthcare (GSK CH India), GlaxoSmithKline, Pfizer Inc, Novartis AG ADR, Biogen Inc, H. Lundbeck AS Class A, Cadila Pharmaceuticals |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 1.8% of the global neuralgia treatment market in 2020.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
- In Middle East & Africa, South Africa neuralgia treatment market is projected to lead the regional market in terms of revenue in 2027.
- Saudi Arabia is the fastest growing regional market in Middle East & Africa and is projected to reach USD 51.9 million by 2027.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Neuralgia Treatment Market Scope
Neuralgia Treatment Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Saudi Arabia neuralgia treatment market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to neuralgia treatment market will help companies and investors design strategic landscapes.
Surgery was the largest segment with a revenue share of 64.13% in 2020. Horizon Databook has segmented the Saudi Arabia neuralgia treatment market based on drug based, surgery covering the revenue growth of each sub-segment from 2016 to 2027.
- Saudi Arabia Neuralgia Treatment Treatment Outlook (Revenue, USD Million, 2016-2027)
- Drug Based
- Anticonvulsant Medicines
- Tricyclic Antidepressants
- Surgery
- Radiofrequency Thermal Lesioning
- Stereotactic Radiosurgery
- Microvascular Decompression
- Others
- Drug Based
- Saudi Arabia Neuralgia Treatment End Use Outlook (Revenue, USD Million, 2016-2027)
- Hospital & Clinics
- Ambulatory Surgery Centers
- Others
Reasons to subscribe to Saudi Arabia neuralgia treatment market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Saudi Arabia neuralgia treatment market databook
-
Our clientele includes a mix of neuralgia treatment market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia neuralgia treatment market, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia neuralgia treatment market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
Partial client list
Saudi Arabia neuralgia treatment market size, by treatment, 2016-2027 (US$M)
Saudi Arabia Neuralgia Treatment Market Share, 2020 & 2027 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
